Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill

Corrinda Black, J. A. Kaye, H. Jick

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aims To estimate the risk of venous thromboembolism among women prescribed the oral contraceptive pill who have acute clinical conditions such as lower limb fractures, compared with women with idiopathic venous thromboembolism.

Methods A nested case-control analysis using the General Practice Research Database, January 1993 to December 1999 was carried out. The participants were women aged 15-39 years, prescribed third generation oral contraceptives (gestodene and desogestrel) or oral contraceptives containing levonorgestrel. The main outcome measures were odds ratios as a measure of the relative risk estimate for venous thromboembolism in women with clinical conditions that predispose to VTE.

Results The adjusted relative risk estimate for venous thromboembolism among patients with the acute clinical conditions, compared with those without such illness, and adjusted for oral contraceptive use, was 17 (95% CI 6.5, 46).

Conclusions This paper documents the strong independent association between certain acute clinical conditions and venous thromboembolism in women prescribed oral contraceptives. Failure to accurately identify and exclude such patients from a study of the effect of oral contraceptives on the risk of venous thromboembolism would result in an underestimate of the risk of venous thromboembolism associated with oral contraceptives.

Original languageEnglish
Pages (from-to)637-640
Number of pages3
JournalBritish Journal of Clinical Pharmacology
Volume53
Issue number6
DOIs
Publication statusPublished - 2002

Keywords

  • clinical risk factors
  • oral contraception
  • venous thromboembolism
  • THROMBOSIS

Cite this

Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill. / Black, Corrinda; Kaye, J. A.; Jick, H.

In: British Journal of Clinical Pharmacology, Vol. 53, No. 6, 2002, p. 637-640.

Research output: Contribution to journalArticle

@article{8054977e9f2544289dec0a1c9d2bf57a,
title = "Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill",
abstract = "Aims To estimate the risk of venous thromboembolism among women prescribed the oral contraceptive pill who have acute clinical conditions such as lower limb fractures, compared with women with idiopathic venous thromboembolism.Methods A nested case-control analysis using the General Practice Research Database, January 1993 to December 1999 was carried out. The participants were women aged 15-39 years, prescribed third generation oral contraceptives (gestodene and desogestrel) or oral contraceptives containing levonorgestrel. The main outcome measures were odds ratios as a measure of the relative risk estimate for venous thromboembolism in women with clinical conditions that predispose to VTE.Results The adjusted relative risk estimate for venous thromboembolism among patients with the acute clinical conditions, compared with those without such illness, and adjusted for oral contraceptive use, was 17 (95{\%} CI 6.5, 46).Conclusions This paper documents the strong independent association between certain acute clinical conditions and venous thromboembolism in women prescribed oral contraceptives. Failure to accurately identify and exclude such patients from a study of the effect of oral contraceptives on the risk of venous thromboembolism would result in an underestimate of the risk of venous thromboembolism associated with oral contraceptives.",
keywords = "clinical risk factors, oral contraception, venous thromboembolism, THROMBOSIS",
author = "Corrinda Black and Kaye, {J. A.} and H. Jick",
year = "2002",
doi = "10.1046/j.1365-2125.2002.01606.x",
language = "English",
volume = "53",
pages = "637--640",
journal = "British Journal of Clinical Pharmacology",
issn = "0306-5251",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill

AU - Black, Corrinda

AU - Kaye, J. A.

AU - Jick, H.

PY - 2002

Y1 - 2002

N2 - Aims To estimate the risk of venous thromboembolism among women prescribed the oral contraceptive pill who have acute clinical conditions such as lower limb fractures, compared with women with idiopathic venous thromboembolism.Methods A nested case-control analysis using the General Practice Research Database, January 1993 to December 1999 was carried out. The participants were women aged 15-39 years, prescribed third generation oral contraceptives (gestodene and desogestrel) or oral contraceptives containing levonorgestrel. The main outcome measures were odds ratios as a measure of the relative risk estimate for venous thromboembolism in women with clinical conditions that predispose to VTE.Results The adjusted relative risk estimate for venous thromboembolism among patients with the acute clinical conditions, compared with those without such illness, and adjusted for oral contraceptive use, was 17 (95% CI 6.5, 46).Conclusions This paper documents the strong independent association between certain acute clinical conditions and venous thromboembolism in women prescribed oral contraceptives. Failure to accurately identify and exclude such patients from a study of the effect of oral contraceptives on the risk of venous thromboembolism would result in an underestimate of the risk of venous thromboembolism associated with oral contraceptives.

AB - Aims To estimate the risk of venous thromboembolism among women prescribed the oral contraceptive pill who have acute clinical conditions such as lower limb fractures, compared with women with idiopathic venous thromboembolism.Methods A nested case-control analysis using the General Practice Research Database, January 1993 to December 1999 was carried out. The participants were women aged 15-39 years, prescribed third generation oral contraceptives (gestodene and desogestrel) or oral contraceptives containing levonorgestrel. The main outcome measures were odds ratios as a measure of the relative risk estimate for venous thromboembolism in women with clinical conditions that predispose to VTE.Results The adjusted relative risk estimate for venous thromboembolism among patients with the acute clinical conditions, compared with those without such illness, and adjusted for oral contraceptive use, was 17 (95% CI 6.5, 46).Conclusions This paper documents the strong independent association between certain acute clinical conditions and venous thromboembolism in women prescribed oral contraceptives. Failure to accurately identify and exclude such patients from a study of the effect of oral contraceptives on the risk of venous thromboembolism would result in an underestimate of the risk of venous thromboembolism associated with oral contraceptives.

KW - clinical risk factors

KW - oral contraception

KW - venous thromboembolism

KW - THROMBOSIS

U2 - 10.1046/j.1365-2125.2002.01606.x

DO - 10.1046/j.1365-2125.2002.01606.x

M3 - Article

VL - 53

SP - 637

EP - 640

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 6

ER -